HIV & AIDS
An aspirin a day may keep HIV away, study finds
An affordable, globally available drug – low-dose Aspirin – shows promise as a new approach to preventing HIV transmission, a University of Manitoba study has found.
Aug 10, 2018
0
60
Journal of Controlled Release
The Journal of Controlled Release is a bimonthly peer-reviewed medical journal and the official journal of the Controlled Release Society. The journal contains papers detailing research involving the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. The journal is abstracted and indexed in BIOSIS Previews, CAB Abstracts, Chemical Abstracts, Current Contents/Life Sciences, EMBASE, MEDLINE, Science Citation Index, and Scopus.
- Publisher
- Elsevier
- History
- 1984-present
- Website
- http://www.elsevier.com/wps/find/journaldescription.cws_home/502690/description#description
- Impact factor
- 7.164 (2010)
Diabetes
Engineers are working on a new device that could streamline blood glucose measurement and insulin
Before consuming a meal, many people with diabetes need to inject themselves with insulin. This is a time-consuming process that often requires estimating the carbohydrate content of the meal, drawing blood to measure blood ...
Jan 20, 2022
0
60
Medical research
Tumor macrophage marker offers unique target for treatment
Macrophages are white blood cells that accumulate in tumors, where they aid cancer progression. Now scientists have identified a surface protein found only on the macrophages residing in tumors, exposing a target for precise ...
Aug 2, 2019
0
152
Immunology
Scientists create device to deliver immunotherapy without side effects
Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this nanofluidic seed makes it possible to deliver ...
Oct 23, 2018
0
603
Oncology & Cancer
Nanodrug targeting breast cancer cells from the inside adds weapon: Immune system attack
A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer ...
Aug 10, 2013
0
0
Parkinson's & Movement disorders
First photoactive drug to fight Parkinson's disease
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.
Jun 8, 2018
0
82
HIV & AIDS
Team develops new way to fight HIV transmission
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
Apr 16, 2018
0
207
Parkinson's & Movement disorders
Ultrasound method restores dopaminergic pathway in brain at Parkinson's early stages
While there are several thousand drugs available to treat a wide range of brain diseases, from depression to schizophrenia, they cannot penetrate the blood-brain barrier (BBB) into the brain. The BBB, which protects the brain ...
Jun 6, 2019
0
915
Ophthalmology
Scientists engineer drug delivery device that treats glaucoma directly inside the eye
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...
Nov 23, 2017
0
54
Oncology & Cancer
Lower, more frequent doses of nanomedicines may enhance cancer treatment
Tiny structures called nanoparticles can be used to carry substances to certain parts of the body—for example, to deliver a chemotherapy drug to a tumor. Although such "nanomedicines" offer hope for improving cancer therapeutics, ...
Mar 11, 2022
0
91
